The Europe anti-viral therapies market is expected to reach US$ 21,122.66 million by 2027 from US$ 11,401.67 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027.
Increasing R&D expenditures of pharmaceutical companies and rising government support for research activities and clinical trials are the key factors driving the growth of the market in this region. However, high cost of drug development is a prime factor hindering the market growth in Europe.
Antiviral therapy is one of the most exciting branches of virology. These therapies are based on several strategies—direct-acting antivirals target viral proteins, enzymes, or nucleic acids; passive antibodies neutralize circulating viruses; and several other antivirals target cellular proteins or processes essential for viral replication.
The clinical trials industry has seen exceptional growth in the last 10 years. More than 600 commercial clinical trials are taking place in the UK National Health Service (NHS). The UK is one of the leading countries in the research and development activities in Europe. Also, the patients in the country are willingly participating in the clinical trials; ~870,250 people were a part of commercial and non-commercial trials. The government is also increasing funds for new research and clinical trials. Vaccine development to fight against COVID-19 is in high pace in the region due to the availability of large group of participants are focusing on clinical trials and forming collaborations to make certain rapid growth and sufficient production capacity. The UK government has launched a new clinical trial program—ACOORD—for the fast track development of new drugs to treat COVID-19. The recovery trial in the UK is currently the largest randomized clinical trial in the world. In Germany, >70% of the clinical trials are being supported by government organizations. The federal ministry of education and research of Germany has launched a pharmaceutical initiative to promote research and development activities. BioNTech and Pfizer have secured approval by German regulatory authority to conduct phase I/II clinical trial of COVID-19 vaccines. For instance, PharmaMar, Spain, has started their phase II clinical trials of a drug named Aplidin to treat COVID-19. Clinical trials of Ivermectin to treat COVID-19 already started. Thus, the biotechnology industry is at the forefront of the fight against COVID-19, contributing through the development of vaccines, therapeutic drugs, and diagnostics solutions. Further, ongoing research on the development of drugs for rare diseases is accelerating the growth of the Europe antiviral therapies market
Europe has witnessed exponential growth in the count of COVID-19 cases. Spain, Italy, Germany, France, and the UK are among the most affected European countries. Growing research activities to develop treatment against corona virus is likely to favor the growth of the market in this region. In June 2020, the scientists from the University of Oxford tested existing drugs as therapies against this novel virus. Further, the European Commission in July authorized the anti-viral drug Remdesivir for its use in the treatment of COVID-19 patients, making it the first approved drug in the European Union for the treatment.
Rest of Europe Anti-Viral Therapies Market, Revenue and Forecast to 2027 (US$ Million)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
EUROPE ANTI-VIRAL THERAPIES MARKET SEGMENTATION
By Type
- Branded Drugs
- Generic Drugs
By Mechanism of Action
- Nucleotide Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Others
By Application
- HIV
- Hepatitis
- Virus Influenza
- Herpes
- Others
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
- AbbVie Inc.
- GlaxoSmithKline plc
- AstraZeneca
- F. HOFFMANN-LA ROCHE LTD
- Johnson and Johnson Services, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Mechanism of Action, and Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Anti-viral therapies Market – By Type
1.3.2 Europe Anti-Viral Therapies Market – By Mechanism of Action
1.3.3 Europe Anti-Viral Therapies Market– By Application
1.3.4 Europe Anti-Viral Therapies Market – By Country
2. Europe Anti-Viral Therapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Anti-Viral Therapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anti-Viral Therapies Market - North America PEST Analysis
4.3 Expert Opinion
4.4 Expert Opinion
5. Europe Anti-Viral Therapies Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing R&D Expenditures in Pharmaceutical Companies
5.1.2 Rising Government Support for Research Activities and Clinical Trials
5.2 Market Restraints
5.2.1 High Cost of Drug Development
5.3 Market Opportunities
5.3.1 Strong Pipeline of Anti-Viral Drugs
5.4 Future Trends
5.4.1 Growing Emphasis on Launching Anti-Viral Agents
5.5 Impact analysis
6. Anti-Viral Therapies Market – Europe Analysis
6.1 Europe Anti-Viral Therapies Market Revenue Forecasts and Analysis
7. Europe Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Type
7.1 Overview
7.2 Europe Anti-Viral Therapies Market, By Type 2019 & 2027 (%)
7.2.1 Europe Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Type (US$ Mn)
7.3 Generic Drugs
7.3.1 Overview
7.3.2 Europe Generic Drugs Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Branded Drugs
7.4.1 Overview
7.4.1.1 Europe Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
8. Europe Anti-Viral Therapies Market Analysis – By Mechanism of Action
8.1 Overview
8.2 Europe Anti-Viral Therapies Market, By Mechanism of Action 2019-2027 (%)
8.2.1 Europe Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Mechanism of Action (US$ Mn)
8.3 Nucleotide Polymerase Inhibitor
8.3.1 Overview
8.3.2 Europe Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Reverse Transcriptase Inhibitors
8.4.1 Overview
8.4.2 Europe Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Protease Inhibitors
8.5.1 Overview
8.5.2 Europe Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Europe Anti-Viral Therapies Market Analysis and Forecasts To 2027 – By Application
9.1 Overview
9.2 Europe Anti-Viral Therapies Market, By Application 2019 & 2027 (%)
9.2.1 Europe Anti-Viral Therapies Market Revenue and Forecasts to 2027, By Application (US$ Mn)
9.3 HIV
9.3.1 Overview
9.3.2 Europe HIV Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Hepatitis
9.4.1 Overview
9.4.2 Europe Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Herpes
9.5.1 Overview
9.5.2 Europe Herpes Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Influenza
9.6.1 Overview
9.6.2 Europe Influenza Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Other Applications
9.7.1 Overview
9.7.2 Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Anti-Viral Therapies Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Europe Anti-Viral Therapies Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Europe: Anti-Viral Therapies Market - Revenue and Forecast to 2027 (USD Million)
10.1.3 Europe: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.4 Europe: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.5 Europe: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.6 Europe: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
10.1.7 Germany: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Germany: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Germany: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.7.3 Germany: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.7.4 Germany: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.8 UK: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UK: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UK: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.8.3 UK: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.8.4 UK: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.9 France: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 France: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 France: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.9.3 France: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.9.4 France: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.10 Spain: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Spain: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Spain: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.10.3 Spain: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.10.4 Spain: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
10.1.11 Italy: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.1 Italy: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.11.2 Italy: Anti-Viral Therapies Market, by Type, 2018–2027 (USD Million)
10.1.11.3 Italy: Anti-Viral Therapies Market, by Mechanism of Action, 2018–2027 (USD Million)
10.1.11.4 Italy: Anti-Viral Therapies Market, by Application, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Anti-viral therapies Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 GlaxoSmithKline plc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 S WOT Analysis
12.1.6 Key Developments
12.2 AstraZeneca
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. HOFFMANN-LA ROCHE LTD.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AbbVie Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson and Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Type (US$ Mn)
Table 2. Europe Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Mechanism of Action (US$ Mn)
Table 3. Europe Anti-Viral Therapies Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 4. Europe Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Europe Anti-Viral Therapies Market, by Mechanism of Action – Revenue and Forecast to 2027 (USD Million)
Table 6. Europe Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. Germany Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Germany Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 9. Germany Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. UK Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. UK Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 12. UK Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. France Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. France Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 15. France Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 16. Spain Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Spain Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Anti-Viral Therapies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Anti-Viral Therapies Market, by Mechanism of Action– Revenue and Forecast to 2027 (USD Million)
Table 21. Italy Anti-Viral Therapies Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 22. Glossary of Terms, Anti-Viral Therapies Market
LIST OF FIGURES
Figure 1. Anti-Viral Therapies Market Segmentation
Figure 2. Europe Anti-Viral Therapies Market Overview
Figure 3. Branded Drugs Segment Held Largest Share of Anti-Viral Therapies Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe Anti-Viral Therapies Market - Leading Country Markets (US$ Mn)
Figure 6. Anti-Viral Therapies Market - North America PEST Analysis
Figure 7. Anti-Viral Therapies Market - Europe PEST Analysis
Figure 8. Anti-Viral Therapies Market Impact Analysis of Driver and Restraints
Figure 9. Europe Anti-viral therapies Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 10. Europe Anti-Viral Therapies Market, By Type 2019 & 2027 (%)
Figure 11. Europe Generic Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe Branded Drugs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Europe Anti-Viral Therapies Market, by Mechanism of Action 2019 & 2027 (%)
Figure 14. Europe Nucleotide Polymerase Inhibitor Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Reverse Transcriptase Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Europe Protease Inhibitors Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Anti-Viral Therapies Market, By Application 2019 & 2027 (%)
Figure 19. Europe HIV Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe Hepatitis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe Herpes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Europe Influenza Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe: Anti-Viral Therapies Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. Europe Anti-Viral Therapies Market Revenue and Forecast to 2027 (USD Million)
Figure 26. Europe: Anti-Viral Therapies Market, by Country, 2019 & 2027 (%)
Figure 27. Germany: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. UK: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. France: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Spain: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Italy: Anti-Viral Therapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in Europe Country Markets
The List of Companies - Europe Anti-Viral Therapies Market
- AbbVie Inc.
- GlaxoSmithKline plc
- AstraZeneca
- F. HOFFMANN-LA ROCHE LTD
- Johnson and Johnson Services, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Anti-Viral Therapies Market
Sep 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)